Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 22/29 November 2014, Vol 293, No 7837/8

Sort by: Newest first Oldest first A-Z Z-A

  • "World Ending" illustration by Jason Clarke, artist with bipolar disorder

    Acute and long-term management of bipolar disorder Subscription

    18 NOV 2014 By Julie Haste
    Comments (9)

    How the latest NICE guidelines affect the recommended treatments for this complex mental health condition.

  • Biomarker test could help reduce unnecessary antibiotic prescribing Subscription

    11 NOV 2014 15:25

    Point-of-care testing for a biomarker of bacterial infection would help to limit unnecessary antibiotic prescribing by GPs, suggests a systematic review.

  • Dear pharmacist, what do you do all day?

    16 OCT 2014 By Elizabeth Sukkar
    Comments (1)

    Elizabeth Sukkar describes study results that suggest it will be “many decades” before community pharmacists’ skills are properly implemented in primary health care.

  • Drug Tariff update Subscription

    14 NOV 2014 15:55

    The Department of Health and National Assembly for Wales have agreed concessionary prices for the following items for November 2014 prescriptions: amantadine capsules 100mg, £19.80, amiloride tablets 5mg, £14.85, co-amilofruse tablets 2.5/20mg, £4.32, 5/40mg, £5.25, co-tenidone tablets 50/12.5mg, £3.55, 100/25mg, £3.55, cyclizine solution for injection ampoules 50mg/ml, £8.65, estriol cream 0.01%, £16.04, exemestane tablets 25mg, £37.95, fenofibrate micronised capsules 200mg, £12.00, ...

  • Dupuytren's NICE draft guidance Subscription

    11 NOV 2014 13:20

    The National Institute for Health and Care Excellence (NICE) has issued draft guidance for consultation that does not recommend collagenase clostridium histolyticum (Xiapex) for the treatment of Dupuytren’s contracture, a condition that causes the fingers of the hands to gradually bend in towards to the palm and cannot be straightened. More information can be found on the NICE website ...

  • Ebola research projects receive £1.34m Subscription

    17 NOV 2014 17:12

    A hand-held device to test bodily fluids for the Ebola virus is among five new research projects announced by the UK government and the Wellcome Trust.

  • Epimax emollient cream Subscription

    14 NOV 2014 11:58

    DermatoLogical is launching Epimax emollient cream that does not contain sodium lauryl sulphate. NHS list price, 500g pump, £2.49 and 100g tube, £0.75.

  • A “procedural error” has led to the annulment of Guido Rasi’s appointment to the position of executive director of the European Medicines Agency in 2011

    European Medicines Agency head steps down after “procedural error” Subscription

    17 NOV 2014 12:24

    Guido Rasi, the executive director of the European Medicines Agency (EMA), has been forced to step down after a “procedural error” in the process that appointed him to the position.

  • ‘Generic: the unbranding of modern medicine’ by Jeremy A Greene

    Exploring the history of generic medicines Subscription

    20 NOV 2014 13:34 By Emma McConnell

    ‘Generic: the unbranding of modern medicine’ by Jeremy A Greene.

  • Famvir side effects Subscription

    10 NOV 2014 11:30

    Abdominal pain and diarrhoea have been added to the list of common side effects in the summary of product characteristics for Famvir (famciclovir; Novartis).

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.